ArticleArthritis research & therapy2022

Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry.

Sae Ochi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.